Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is an anticonvulsant presented as an oral formulation for oral use. It is prescribed for partial seizures, postherpetic neuralgia, neuropathic pain, and restless legs syndrome in adult patients when other therapies are insufficient and is often used as part of combination therapy.

GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance throughout Europe.

Gabapentin is used to manage neurological and pain‑related conditions that involve abnormal neuronal excitability.

Partial seizures: reduces seizure frequency in patients with focal epilepsy. Postherpetic neuralgia: alleviates chronic pain following shingles. Neuropathic pain: diminishes pain intensity in diabetic or peripheral nerve injury. Restless legs syndrome: improves uncomfortable leg sensations and urges to move.

Adverse reactions may occur with gabapentin therapy.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities. - Visual disturbances: blurred vision or double vision. - Weight gain: modest increase in body weight. - Gastrointestinal upset: nausea or constipation.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal ideation: emergence of depressive thoughts or self‑harm. - Respiratory depression: especially when combined with other CNS depressants. - Anaphylaxis: rare but potentially life‑threatening allergic response. - Blood dyscrasias: thrombocytopenia or leukopenia.

Patients should be evaluated for specific risk factors before initiating gabapentin therapy.

Renal function: adjust dose in patients with impaired kidney function. Pregnancy: risk unknown; prescribe only if potential benefit justifies potential fetal risk. Elderly: monitor for falls, confusion and increased sedation. Concomitant CNS depressants: may enhance sedative effects; use caution. Avoid abrupt discontinuation: taper dose gradually to prevent withdrawal symptoms. Store at room temperature: keep in the original pack, protect from moisture.

Gabapentin may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption. - Opioids: increase risk of respiratory depression and profound sedation. - Alcohol: may potentiate central nervous system depression.

Moderate Interactions (Monitor Closely): - Benzodiazepines: additive sedative effect, monitor drowsiness. - Diuretics: may raise gabapentin plasma concentrations. - ACE inhibitors: monitor renal function and electrolytes. - Carbamazepine: may lower gabapentin efficacy, consider dose adjustment.